1. Aventis Pharma Australia. Arava product information. Approved by TGA 28 September 1999; Safety related notification 2 November 1999.
2. Commonwealth of Australia. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners 1 February 2002: 183
3. Council for International Organizations of Medical Sciences (CIOMS) 1999. Reporting Adverse Drug Reactions—Definitions of Terms and Criteria for their Use, White Blood Cell and RES (Reticulo-endothelial system) disorders (SOC 1220): 102.
4. Commonwealth of Australia. Australian Statistics on Medicines 2001-2002. Available from URL: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pbs-general-pubs-asm.htm [Accessed 2005 October 26].